Bank of New York Mellon’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-132,393
| Closed | -$115K | – | 4440 |
|
|
2023
Q2 | $115K | Hold |
132,393
| – | – | ﹤0.01% | 4069 |
|
|
2023
Q1 | $92.5K | Hold |
132,393
| – | – | ﹤0.01% | 4088 |
|
|
2022
Q4 | $109K | Sell |
132,393
-48,352
| -27% | -$47.7K | ﹤0.01% | 4099 |
|
|
2022
Q3 | $187K | Sell |
180,745
-2,337
| -1% | -$3.73K | ﹤0.01% | 4045 |
|
|
2022
Q2 | $301K | Sell |
183,082
-97,124
| -35% | -$202K | ﹤0.01% | 3875 |
|
|
2022
Q1 | $824K | Buy |
280,206
+2,366
| +0.9% | +$8.29K | ﹤0.01% | 3425 |
|
|
2021
Q4 | $1.33M | Buy |
277,840
+51,300
| +23% | +$331K | ﹤0.01% | 3221 |
|
|
2021
Q3 | $1.72M | Buy |
226,540
+67,243
| +42% | +$430K | ﹤0.01% | 3082 |
|
|
2021
Q2 | $1.19M | Buy |
159,297
+82,268
| +107% | +$634K | ﹤0.01% | 3300 |
|
|
2021
Q1 | $601K | Buy |
77,029
+1,401
| +2% | +$14K | ﹤0.01% | 3591 |
|
|
2020
Q4 | $699K | Buy |
75,628
+5,329
| +8% | +$46.3K | ﹤0.01% | 3452 |
|
|
2020
Q3 | $485K | Buy |
+70,299
| New | +$426K | ﹤0.01% | 3504 |
|
|
2019
Q4 | – | Sell |
-30,979
| Closed | -$44K | – | 4248 |
|
|
2019
Q3 | $44K | Sell |
30,979
-7,468
| -19% | -$16.3K | ﹤0.01% | 4134 |
|
|
2019
Q2 | $108K | Sell |
38,447
-21,437
| -36% | -$85.3K | ﹤0.01% | 4017 |
|
|
2019
Q1 | $286K | Sell |
59,884
-1,216
| -2% | -$5.98K | ﹤0.01% | 3759 |
|
|
2018
Q4 | $259K | Buy |
61,100
+45,910
| +302% | +$355K | ﹤0.01% | 3764 |
|
|
2018
Q3 | $166K | Hold |
15,190
| – | – | ﹤0.01% | 3968 |
|
|
2018
Q2 | $248K | Buy |
+15,190
| New | +$220K | ﹤0.01% | 3874 |
|
Bank of New York Mellon's SURF Position: Q3 2023 in Review
Bank of New York Mellon sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 132,393 shares — an estimated $115K sold.
Bank of New York Mellon first reported a position in SURF in Q2 2018 and held it in 18 quarters. The position peaked at $1.72M in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- Bank of New York Mellon reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Bank of New York Mellon sold 132,393 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $115K.
- Bank of New York Mellon first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
- Bank of New York Mellon's Surface Oncology, Inc. Common Stock position peaked at $1.72M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.